| Rebecca A French, ARNP-C | |
|
1408 East Street, Iola, KS 66749-3004 | |
| (620) 365-3115 | |
| (620) 365-7717 |
| Full Name | Rebecca A French |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1408 East Street, Iola, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619169398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 46068 (Kansas) | Primary |
| Entity Name | Community Health Center Of Southeast Kansas Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669474425 PECOS PAC ID: 7911816392 Enrollment ID: O20040209000163 |
News Archive
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for its compound AEZS-108 for the treatment of ovarian cancer. AEZS-108, the Company's doxorubicin targeted conjugate compound, is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.
Politico and Kaiser Health News provide progress reports related to the development of the health law's new online insurance marketplaces.
Many donor kidneys that are transplanted are rejected by the recipient within ten years after transplantation.
In this episode of the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald, vice president for communications and policy outreach at the CGD, interviews Amanda Glassman, a research fellow and director of CGD's global health program, about her recent report, Priority Setting in Health: Building Institutions for Smarter Public Spending, which "draws on the expertise of a CGD working group to offer recommendations for improving the allocation of scarce health funding, despite political and bureaucratic constraints."
Viral conjunctivitis is a highly contagious infection, often causing major ophthalmic epidemics. There is no approved acute treatment currently approved by the FDA for viral conjunctivitis. A safe broad-spectrum antiviral agent is needed to treat this unmet medical need.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rebecca A French, ARNP-C 1408 East Street, Iola, KS 66749-3004 Ph: (620) 365-3115 | Rebecca A French, ARNP-C 1408 East Street, Iola, KS 66749-3004 Ph: (620) 365-3115 |
News Archive
Aeterna Zentaris Inc. a late-stage drug development company specialized in oncology and endocrinology, today announced that it has received a positive opinion for orphan medicinal product designation from the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency, for its compound AEZS-108 for the treatment of ovarian cancer. AEZS-108, the Company's doxorubicin targeted conjugate compound, is currently in a Phase 2 trial in advanced ovarian and advanced endometrial cancer in Europe.
Politico and Kaiser Health News provide progress reports related to the development of the health law's new online insurance marketplaces.
Many donor kidneys that are transplanted are rejected by the recipient within ten years after transplantation.
In this episode of the Center for Global Development's (CGD) "Global Prosperity Wonkcast," Lawrence MacDonald, vice president for communications and policy outreach at the CGD, interviews Amanda Glassman, a research fellow and director of CGD's global health program, about her recent report, Priority Setting in Health: Building Institutions for Smarter Public Spending, which "draws on the expertise of a CGD working group to offer recommendations for improving the allocation of scarce health funding, despite political and bureaucratic constraints."
Viral conjunctivitis is a highly contagious infection, often causing major ophthalmic epidemics. There is no approved acute treatment currently approved by the FDA for viral conjunctivitis. A safe broad-spectrum antiviral agent is needed to treat this unmet medical need.
› Verified 4 days ago
Mrs. Dena L Splitter, ARNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1408 East Street, Iola, KS 66749 Phone: 620-365-3115 Fax: 620-365-7717 | |
Ms. Stacey Kale, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1408 East St, Iola, KS 66749 Phone: 620-365-3115 Fax: 620-365-7717 | |
Koralyn Dawn Barkman, APRN-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2051 N State St, Iola, KS 66749 Phone: 203-806-6006 Fax: 620-380-6215 | |
Annette Diane Vananne, ARNP, CNM Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2051 N State St, Iola, KS 66749 Phone: 620-380-6600 Fax: 620-380-6215 | |
Anissa Lynn Sell, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3066 N Kentucky St, Iola, KS 66749 Phone: 620-365-1185 Fax: 620-365-1038 | |
Margaret L Lesher, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 401 S Washington Ave, Iola, KS 66749 Phone: 620-365-6933 Fax: 620-365-8126 |